Gene therapy for the regeneration of bone

Injury

Volumn 42, Issue 6, 2011, Pages 599-604

  Evans, Christopher ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b AO FOUNDATION   (Switzerland)

Author keywords

Adeno associated virus; Adenovirus; Allograft revitalization; Animal model; Clinical trial; Gene activated matrix; Osteoblast; Osteoprogenitor cell; Vector

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; CONSTITUTIVELY ACTIVE ALK 2 RECEPTOR; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; HERPES SIMPLEX VIRUS VECTOR; LENTIVIRUS VECTOR; LIM PROTEIN; LIM PROTEIN 1; LIM PROTEIN 3; NEL LIKE MOLECULE 1; ONCORETROVIRUS VECTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE[1-34]; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN; RECEPTOR PROTEIN; SOMATOMEDIN C; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS DNA; VIRUS VECTOR;

BONE DEFECT; BONE DEVELOPMENT; BONE GRAFT; BONE REGENERATION; DNA MODIFICATION; DRUG SAFETY; EX VIVO STUDY; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSFECTION; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENOME;

EID: 79957797244     PISSN: 00201383     EISSN: 18790267     Source Type: Journal    
DOI: 10.1016/j.injury.2011.03.032     Document Type: Article

References (75)

1. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008;358:2231-9. (Pubitemid 351724452)
2. Baltzer AW, Lattermann C, Whalen JD, et al. A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealand white rabbit model. Knee Surg Sports Traumatol Arthrosc 1999;7:197-202.
3. Baltzer AW, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000;7:734-9. (Pubitemid 30255754)
4. Betz OB, Betz VM, Nazarian A, et al. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 2007;14:1039-44. (Pubitemid 46965273)
5. Betz OB, Betz VM, Nazarian A, et al. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am 2006;88:355-65. (Pubitemid 43185138)
6. Betz VM, Betz OB, Glatt V, et al. Healing of segmental bone defects by direct percutaneousgenedelivery: effectofvectordose.HumGeneTher2007;18:907-15.
7. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-9. (Pubitemid 29318608)
8. Breitbart AS, Grande DA, Mason JM, et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999;42:488-95. (Pubitemid 29218313)
9. Burnett JR, Hooper AJ. Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency. Curr Opin Mol Ther 2009;11:681-91.
10. Carofino BC, Lieberman JR. Gene therapy applications for fracture-healing. J Bone Joint Surg Am 2008;90(Suppl. 1):99-110. (Pubitemid 351329128)
11. Chang PC, Cirelli JA, Jin Q, et al. Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther 2009;20:486-96.
12. Chang SC, Lin TM, Chung HY, et al. Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials. Neurosurgery 2009;65(75-81). [discussion 3].
13. Chen L, Tredget EE, Liu C, Wu Y. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One 2009;4:e7119.
14. Dai J, Rabie AB. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007;86:937-50.
15. Dai KR, Xu XL, Tang TT, et al. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005;77:55-61. (Pubitemid 41504173)
16. Deschaseaux F, Sensebe L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med 2009;15:417-29.
17. Egermann M, Baltzer AW, Adamaszek S, et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 2006;17:507-17. (Pubitemid 43794490)
18. Egermann M, Lill CA, Griesbeck K, et al. Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther 2006;13:1290-9. (Pubitemid 44264083)
19. El Tamer MK, Reis RL. Progenitor and stem cells for bone and cartilage regeneration. J Tissue Eng Regen Med 2009;3:327-37.
20. Evans CH. Gene therapy for bone healing. Expert Rev Mol Med 2010;12:e18. 10.1017/S1462399410001493.
21. Evans CH, Ghivizzani SC, Robbins PD. Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol. 2010 Dec 7. [Epub ahead of print].
22. Evans CH, Liu FJ, Glatt V, et al. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 2009;18:96-111.
23. Evans CH, Palmer GD, Pascher A, et al. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 2007;13: 1987-93. (Pubitemid 47293994)
24. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996;93:5753-8. (Pubitemid 26190752)
25. Gazit D, Turgeman G, Kelley P, et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999;1:121-33. (Pubitemid 129631069)
26. Guo X, Zheng Q, Kulbatski I, et al. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Biomed Mater 2006;1:93-9. (Pubitemid 44529332)
27. Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010;363:355-64.
28. Heilbronn R, Weger S. Viral vectors for gene transfer: current status of gene therapeutics. Handb Exp Pharmacol 2010:143-70.
29. Helm GA, Alden TD, Beres EJ, et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000;92:191-6. (Pubitemid 30207415)
30. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008;10:771-4.
31. Ishihara A, Shields KM, Litsky AS, et al. Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. J Orthop Res 2008;26:764-71.
32. Ishihara A, Zekas LJ, Litsky AS, et al. Dermal fibroblast-mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model. J Orthop Res 2010;28:403-11.
33. Ito H, Koefoed M, Tiyapatanaputi P, et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005;11:291-7. (Pubitemid 40460557)
34. Ito T, Tokunaga K, Maruyama H, et al. Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing. Gene Ther 2003;10:1623-8. (Pubitemid 37063269)
35. Koefoed M, Ito H, Gromov K, et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 2005;12:212-8. (Pubitemid 41025090)
36. Koh JT, Zhao Z, Wang Z, et al. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 2008;87:845-9.
37. Kwong FN, Harris MB. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 2008;16:619-25.
38. Kwong FN, Richardson SM, Evans CH. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 2008;10:R65.
39. Lattanzi W, Parrilla C, Fetoni A, et al. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther 2008;15:1330-43.
40. Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2- expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001;83-A:1032-9. (Pubitemid 32662105)
41. Li BC, Zhang JJ, Xu C, et al. Treatment of rabbit femoral defect by firearm with BMP-4 gene combined with TGF-beta1. J Trauma 2009;66:450-6.
42. Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999;81:905-17. (Pubitemid 29354999)
43. Lieberman JR, Le LQ, Wu L, et al. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998;16:330-9. (Pubitemid 28337629)
44. Lu SS, Zhang X, Soo C, et al. The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J 2007;7:50-60. (Pubitemid 46002542)
45. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358:2240-8. (Pubitemid 351724453)
46. Miyazaki M, Sugiyama O, Tow B, et al. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Spinal Disord Tech 2008;21:372-9.
47. Miyazaki M, Sugiyama O, Zou J, et al. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Philadelphia PA 1976) 2008;33:1410-7.
48. Nauth A, Miclau 3rd T, Li R, Schemitsch EH. Gene therapy for fracture healing. J Orthop Trauma; 24 Suppl. 1 S17-24.
49. Pape HC, Evans A, Kobbe P. Autologous bone graft: properties and techniques. J Orthop Trauma; 24 Suppl. 1 S36-40.
50. Pascher A, Palmer GD, Steinert A, et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 2004;11:133-41. (Pubitemid 38159685)
51. Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector-mediated gene delivery. Biotechnol J 2009;4:1559-72.
52. Pelled G, Ben-Arav, A, Hock, C, et al. Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng Part B Rev 16, 13-20.
53. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002;110:751-9.
54. Peterson B, Iglesias R, Zhang J, et al. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine (Philadelphia PA 1976) 2005;30:283-9. [discussion 9-90].
55. Peterson B, Zhang J, Iglesias R, et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005;11:120-9. (Pubitemid 40515180)
56. Rundle CH, Miyakoshi N, Kasukawa Y, et al. In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. Bone 2003;32:591-601.
57. Rundle CH, Strong DD, Chen ST, et al. Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat. J Gene Med 2008;10:229-41.
58. Scotti C, Tonnarelli B, Papadimitropoulos A, et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A 2010;107:7251-6.
59. Shen FH, Visger JM, Balian G, et al. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma 2002;16:651-9. (Pubitemid 35214856)
60. Shin JH, Kim KH, Kim SH, et al. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats. J Clin Periodontol 2010;37:305-11.
61. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-7.
62. Sonobe J, Okubo Y, Kaihara S, et al. Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response. Hum Gene Ther 2004;15:659-68. (Pubitemid 38925218)
63. Strohbach CA, Rundle CH, Wergedal JE, et al. LMP-1 retroviral gene therapy influences osteoblast differentiation and fracture repair: a preliminary study. Calcif Tissue Int 2008;83:202-11.
64. Sundelacruz S, Kaplan DL. Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol 2009;20:646-55.
65. Tang TT, Lu B, Yue B, et al. Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 2007;89:127-9.
66. Tsuchida H, Hashimoto J, Crawford E, et al. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res 2003;21:44-53. (Pubitemid 36157619)
67. Tu Q, Valverde P, Li S, et al. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 2007;13:2431-40. (Pubitemid 47571707)
68. Ulstrup AK. Biomechanical concepts of fracture healing in weight-bearing long bones. Acta Orthop Belg 2008;74:291-302.
69. Viggeswarapu M, Boden SD, Liu Y, et al. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 2001;83-A:364-76. (Pubitemid 32221566)
70. Virk MS, Conduah A, Park SH, et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008;42:921-31.
71. Wan DC, Pomerantz JH, Brunet LJ, et al. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 2007;282:26450-9.
72. Xu XL, Tang T, Dai K, et al. Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop 2005;76:637-46.
73. Yi Y, Choi KB, Lim CL, et al. Irradiated human chondrocytes expressing bone morphogenetic protein 2 promote healing of osteoporotic bone fracture in rats. Tissue Eng Part A 2009;15:2853-63.
74. Zhao Z, Wang Z, Ge C, et al. Healing cranial defects with AdRunx2-transduced marrow stromal cells. J Dent Res 2007;86:1207-11.
75. Zhu W, Rawlins BA, Boachie-Adjei O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 2004;19:2021-32.